article thumbnail

Alfacalcidol and Calcitriol

RX Note

Introduction Vitamin D is a range of compounds which possess the property of preventing or curing rickets. The previous 2011 product monograph recommended that the drops be keep refrigerated (2-8°C) and use within 28 days of first opening the bottle.

article thumbnail

The role of outsourcing in antibody drug manufacture

European Pharmaceutical Review

stated that when conventional small-molecule compounds were the norm within the industry, closed innovation was standard practise and pharmaceutical companies did R&D in-house. Yet from 2011, these arrangements were the subject of “patent-non- exclusive rights, technology- exclusive rights and technology-supply”. Yoshiura et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dilution Protocol

RX Note

ASHP Injectable Drug Information, 2022 Australian Injectable Drug Handbooks, 2020 - free trial is available Davis's Drug Guide for Nurses, 2022 Elsevier's 2023 Intravenous Medications, 2022 External Stability for Parenteral Drugs, 2022 GlobalRPh IV Dilutions Medication Reference and Infusion Guidelines Injectable Drugs Guide, 2011 King Guide Pediatric (..)

article thumbnail

Recommended Medical Reference

RX Note

Adverse Drug Reaction Drug Induced Diseases, 2018 Meyler's Side Effects of Drugs, 2015 Antibiotics The Sanford Guide to Antimicrobial Therapy, 2022 Breastfeeding Briggs' Drugs in Pregnancy and Lactation, 2021 Hale's Medications and Mothers' Milk, 2021 Clinical Practice Applied Therapeutics, 2018 Conn’s Current Therapy, 2022 Current Medical Diagnosis (..)

article thumbnail

New approvals to revolutionise myelofibrosis treatment landscape across 8MM: GlobalData

Express Pharma

billion in 2031 across the 8MM, registering a compound annual growth rate (CAGR) of 1.9 Jakafi’s landmark approval in 2011 galvanised intensive drug development efforts by providing a strong positive investment signal for this market, as Jakafi is a blockbuster agent. billion in 2021 to $2.89

article thumbnail

Seagen wins Enhertu patent dispute with Daiichi Sankyo

pharmaphorum

10,808,039) covering ADCs that include auristatin compounds coupled to an antibody via a linker molecule. Seagen has a long history in ADC development, claiming FDA approval for Adcetris (brentuximab vedotin) as a treatment for classical Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL) in 2011.

article thumbnail

Lilly revives ImmunoGen ADC pact with new $1.7bn deal

pharmaphorum

Lilly originally agreed paid $20 million upfront for a license to the maytansinoid technology in 2011, and expanded the partnership two years later, only to exit the agreement in 2018.